Arbutus Biopharma Corp Proceeds from Income Tax Refunds
Arbutus Biopharma Corp (ABUS) reported Proceeds from Income Tax Refunds of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIncomeTaxRefunds · last filed 2019-03-07
CAD
| Period end | Proceeds from Income Tax Refunds 12 month |
|---|---|
| 2012-12-31 | 321.21K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 102.46K CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 36.61K CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | 275.96K CAD 20-F · filed 2012-03-27 |
USD
| Period end | Proceeds from Income Tax Refunds 3 month | Proceeds from Income Tax Refunds 6 month | Proceeds from Income Tax Refunds 9 month | Proceeds from Income Tax Refunds 12 month | Proceeds from Income Tax Refunds 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $0.00 derived: sum of 2 quarters · filed 2019-03-07 | $0.00 derived: sum of 3 quarters · filed 2019-03-07 | $0.00 10-K · filed 2019-03-07 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 4 quarters · filed 2019-03-07 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | $0.00 derived: sum of 3 quarters · filed 2019-03-07 | $108.00K derived: sum of 4 quarters · filed 2019-03-07 | |
| 2018-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2019-03-07 | $0.00 derived: sum of 2 quarters · filed 2019-03-07 | $108.00K derived: sum of 3 quarters · filed 2019-03-07 | $216.00K derived: sum of 4 quarters · filed 2019-03-07 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $108.00K derived: sum of 2 quarters · filed 2019-03-07 | $216.00K derived: sum of 3 quarters · filed 2019-03-07 | $108.00K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $108.00K 10-Q · filed 2018-11-07 | $216.00K derived: sum of 2 quarters · filed 2018-11-07 | $108.00K 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $108.00K 10-Q · filed 2018-08-03 | $108.00K 10-Q · filed 2018-08-03 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $0.00 10-K · filed 2018-03-16 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $25.00K derived: sum of 3 quarters · filed 2018-03-16 | $24.00K 10-K · filed 2018-03-16 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | $25.00K derived: sum of 2 quarters · filed 2016-11-03 | $24.00K 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $25.00K 10-Q · filed 2016-08-04 | $25.00K 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $0.00 derived: sum of 2 quarters · filed 2017-03-22 | $0.00 10-K · filed 2017-03-22 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $10.00K 10-K · filed 2016-03-09 | $9.88K 6-K · filed 2014-03-06 | ||
| 2013-09-30 | $10.00K 10-Q · filed 2014-11-07 | ||||
| 2013-06-30 | $10.00K 10-Q · filed 2014-11-07 | ||||
| 2012-12-31 | $323.00K 10-K · filed 2015-03-13 | $322.72K 6-K · filed 2014-03-06 | |||
| 2011-12-31 | $103.66K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |